Risk of Merkel cell carcinoma after solid organ transplantation

Journal of the National Cancer Institute

Volumn 107, Issue 2, 2015, Pages

  Clarke, Christina A ^a,b   Robbins, Hilary A ^c   Tatalovich, Zaria ^c   Lynch, Charles F ^d   Pawlish, Karen S ^e   Finch, Jack L ^f   Hernandez, Brenda Y ^g   Fraumeni, Joseph F ^c   Madeleine, Margaret M ^h,i   Engels, Eric A ^c  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^f Air Pollution Control Division   (United States)

^g UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MONOCLONAL ANTIBODY; MYCOPHENOLATE MOFETIL; POLYCLONAL ANTIBODY; TACROLIMUS; PHOTOSENSITIZING AGENT; TARGET OF RAPAMYCIN KINASE;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; EUROPEAN AMERICAN; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LATITUDE; MAINTENANCE THERAPY; MALE; MERKEL CELL TUMOR; MIDDLE AGED; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; YOUNG ADULT; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; CARCINOMA, MERKEL CELL; IMMUNOCOMPROMISED PATIENT; POISSON DISTRIBUTION; PROCEDURES; REGISTER; REMISSION; RISK ASSESSMENT; RISK FACTOR; SKIN NEOPLASMS; UNITED STATES;

ADULT; AGED; AZATHIOPRINE; CARCINOMA, MERKEL CELL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PHOTOSENSITIZING AGENTS; POISSON DISTRIBUTION; REGISTRIES; REMISSION INDUCTION; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; TOR SERINE-THREONINE KINASES; TRANSPLANT RECIPIENTS; ULTRAVIOLET RAYS; UNITED STATES;

EID: 84925546956     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju382     Document Type: Article

References (31)

1. Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer. 2011;47(4):579-585.
2. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832-841.
3. Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst. 2010;102(11):793-801.
4. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8(2):153-158.
5. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096-1100.
6. An KP, Ratner D. Merkel cell carcinoma in the setting of HIV infection. J Am Acad Dermatol. 2001;45(2):309-312.
7. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet. 2002;359(9305):497-498.
8. Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB. Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1545-1549.
9. Eftekhari F, Wallace S, Silva EG, Lenzi R. Merkel cell carcinoma of the skin: imaging and clinical features in 93 cases. Br J Radiol. 1996;69(819):226-233.
10. Gooptu C, Woollons A, Ross J, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol. 1997;137(4):637-641.
11. Lanoy E, Costagliola D, Engels EA, et al. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer. 2010;126(7):1724-1731.
12. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation. 1999;68(11):1717-1721.
13. Attard NR, Karran P. UVA photosensitization of thiopurines and skin cancer in organ transplant recipients. Photochem Photobiol Sci. 2012;11(1):62-68.
14. Han W, Soltani K, Ming M, He YY. Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis. Cancer Prev Res (Phila). 2012;5(9):1155-1162.
15. Herman M, Weinstein T, Korzets A, et al. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med. 2001;137(1):14-20.
16. Hofbauer GF, Attard NR, Harwood CA, et al. Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine. Am J Transplant. 2012;12(1):218-225.
17. Yarosh DB, Pena AV, Nay SL, Canning MT, Brown DA. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol. 2005;125(5):1020-1025.
18. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309(5742):1871-1874.
19. Krynitz B, Edgren G, Lindelof B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer. 2013;132(6):1429-1438.
20. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17):1891-1901.
21. CivicSpace Labs. CivicSpace US ZIP Code Database. 2004 [3/30/2014]; Available at: http://www.boutell.com/zipcodes/.
22. Tatalovich Z, Wilson JP, Cockburn MG. A Comparison of Thiessen Polygon, Kriging, and Spline Models of Potential UV Exposure. Cartography and Geographic Information Science. 2006;33(3):217-237.
23. Tatalovich Z, Wilson JP, Mack T, Yan Y, Cockburn M. The objective assessment of lifetime cumulative ultraviolet exposure for determining melanoma risk. J Photochem Photobiol B. 2006;85(3):198-204.
24. Perrett CM, Walker SL, O'Donovan P, et al. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol. 2008;159(1):198-204.
25. Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:162-178.
26. Balagula Y, Kang S, Patel MJ. Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients. Photodermatol Photoimmunol Photomed. 2014; In press.
27. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest. 2011;121(9):3623-3634.
28. Arora R, Shuda M, Guastafierro A, et al. Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med. 2012;4(133):133ra56.
29. Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant. 2006;6(5 Pt 2):1111-1131.
30. Stirnemann PM, Takemoto SK, Schnitzler MA, et al. Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol. 2006;17(8):2299-2306.
31. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S. Skin cancer in organ transplant recipients-where do we stand today? Am J Transplant. 2008;8(11):2192-2198.